3-Methylquinoxalin-2(1H)-one - CAS 14003-34-0
Catalog: |
BB009024 |
Product Name: |
3-Methylquinoxalin-2(1H)-one |
CAS: |
14003-34-0 |
Synonyms: |
3-methyl-1H-quinoxalin-2-one; 3-methyl-1H-quinoxalin-2-one |
IUPAC Name: | 3-methyl-1H-quinoxalin-2-one |
Description: | 3-Methylquinoxalin-2(1H)-one (CAS# 14003-34-0) is a useful research chemical. |
Molecular Weight: | 160.17 |
Molecular Formula: | C9H8N2O |
Canonical SMILES: | CC1=NC2=CC=CC=C2NC1=O |
InChI: | InChI=1S/C9H8N2O/c1-6-9(12)11-8-5-3-2-4-7(8)10-6/h2-5H,1H3,(H,11,12) |
InChI Key: | BMIMNRPAEPIYDN-UHFFFAOYSA-N |
Boiling Point: | 345.6 °C at 760 mmHg |
Density: | 1.26 g/cm3 |
Solubility: | >24 [ug/mL] (The mean of the results at pH 7.4) |
Appearance: | Yellow crystalline |
Storage: | Sealed in dry, 2-8 °C |
LogP: | 1.64380 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112812069-A | Synthetic method of 3-methyl-3-quinolol | 20210221 |
US-2021323911-A1 | Methods of forming imines, imine-related and imine-derived compounds using green solvents | 20200417 |
WO-2021175203-A1 | Aie probe and application thereof | 20200302 |
CN-111116497-A | Preparation method of 3-methylquinoxaline-2- (1H) -one derivative | 20191120 |
CN-111116497-B | Preparation method of 3-methylquinoxaline-2- (1H) -one derivative | 20191120 |
PMID | Publication Date | Title | Journal |
31893549 | 20200215 | Design, synthesis and biological evaluation of quinoxaline compounds as anti-HIV agents targeting reverse transcriptase enzyme | European journal of medicinal chemistry |
21754764 | 20110601 | N'-(3-Methyl-quinoxalin-2-yl)-N'-phenyl-benzohydrazide | Acta crystallographica. Section E, Structure reports online |
21579110 | 20100410 | 3-[2-(3-Methyl-quinoxalin-2-yl-oxy)eth-yl]-1,3-oxazolidin-2-one | Acta crystallographica. Section E, Structure reports online |
11170649 | 20010215 | Structure-activity studies of substituted quinoxalinones as multiple-drug-resistance antagonists | Journal of medicinal chemistry |
Complexity: | 235 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 160.063662883 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 160.063662883 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 41.5 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoxalines
Customers Also Viewed
-
[471915-89-6]
N-(3,4-Dihydroxyphenethyl)methacrylamide
-
[1118-71-4]
2,2,6,6-Tetramethyl-3,5-heptanedione
-
[582-16-1]
2,7-Dimethylnaphthalene
-
[44994-28-7]
N,N,N',N'-Tetramethyl-1,5-pentanediamine
-
[597-35-3]
ethylsulfone
-
[6315-52-2]
Ethylene di(p-toluenesulfonate)
INDUSTRY LEADERS TRUST OUR PRODUCTS